Brigit Biofarmaka Teknologi Tbk. vs Satyamitra Kemas Lestari Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Satyamitra Kemas Lestari Tbk. trades at Rp141 (market cap 471.7B, 327.2K 24h volume). The key difference: Satyamitra Kemas Lestari Tbk. is far larger — about 2.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Satyamitra Kemas Lestari Tbk. is more actively traded (327.2K versus 218.7K). Which is the better fit depends on your goals.
| OBAT | SMKL | |
|---|---|---|
Market Cap | 172.82B | 471.7B |
Volume | 218.7K | 327.2K |
Lot | 2.19K | 3.27K |
Turnover | 53.51M | 45.01M |
Average Price | 244.66 | 137.57 |
Value | 53.51M | 45.01M |
Indicative Equilibrium Price | 252 | 141 |
Indicative Equilibrium Volume | 48 | 392 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.
Read more on SMKL →